Company attributes
Other attributes
Accellta is a company that is developing technology to culture induced pluripotent stem cells, progenitors, and other cells. Accellta offers a range of solutions for better affordability and quality of stem cell culturing and its technologies are the result of over fifteen years of pioneering research and development at the Stem Cell Center in the Technion’s Rappaport Faculty of Medicine.
Accellta provides custom-made solutions for mass production of quality human embryonic and induced pluripotent stem cells, progenitors and differentiated cells for drug discovery, regenerative medicine, and research.
Accellta operates a fully equipped top-tier manufacturing facility designed according to GMP guidelines for industrial manufacturing of cells. The facility includes over 550 sqm of clean room (88 sqm), QC laboratories, research laboratories and offices located at the Technion in Haifa, Israel.
